Newly Profitable Medivation Riding High On Drug Sales
Alexion's Soliris Gets Final Positive NICE Recommendation
1:28 am Alexion Pharma NICE issues Final Positive Recommendation for National Commissioning of Soliris for all patients with aHUS in England
NICE Issues Final Positive Recommendation for National Commissioning of Soliris (eculizumab) for All Patients with aHUS in England
NICE Issues Final Positive Recommendation for National Commissioning of Soliris (eculizumab) for All Patients with aHUS in England
UK set to give green light for expensive kidney drug
Alexion's (ALXN) Soliris Gets Orphan Drug Status in Japan
Soliris (eculizumab) Granted Orphan Drug Designation in Japan for the Treatment of Patients with Neuromyelitis Optica
Has Alexion Pharmaceuticals Healed From Its Bad Break?
Are consumers getting gouged on health care?
Here Are Some Big Caps Poised To Make Gains
Longer-term Outcome Data from the Largest Prospective Trial of Soliris (eculizumab) in aHUS Underscore the Effectiveness of Ongoing Soliris Treatment
Alexion, EA: Two Top Stocks Form Good Chart Patterns
Taking Stock: Iqbal Favors Oil, Transportation, Health Care
Big Cap 20 Stuffed With Medical Names
ALEXION PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E
Alexion Pharma co-founder Squinto to retire
Alexion Pharma co-founder Squinto to retire
Alexion Announces Planned Retirement of Stephen Squinto, Ph.D., Company Co-Founder and Chief Global Operations Officer, in January 2015
Alexion Announces Planned Retirement of Stephen Squinto, Ph.D., Company Co-Founder and Chief Global Operations Officer, in January 2015
Here's Why Alexion Pharmaceuticals (ALXN) Stock May Rise In Today's Holiday ...
Is Alexion Pharmaceuticals Inc Poised for Years of Dominance?
Alexion Pharmaceuticals Now #122 Largest Company, Surpassing Praxair
Pharma Stocks To Watch: Alexion Pharmaceuticals (ALXN), Avanir ...
Why Lorillard, Inc., Alexion Pharmaceuticals, Inc., and Coach, Inc. Are Today ...
Commit To Purchase Alexion Pharmaceuticals At $95, Earn 5.4% Using Options
Investor's Update: Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)
Why Vertex Pharmaceuticals Incorporated, Alexion Pharmaceuticals, Inc., and ...
Why Alexion Pharmaceuticals (ALXN) Could Be an Impressive Growth Stock
Agree To Buy Alexion Pharmaceuticals At $110, Earn 6.4% Using Options
